Advertisement
As of 01:20PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 69.22 |
| Open | 69.20 |
| Bid | 68.38 x 1000 |
| Ask | 68.42 x 1000 |
| Day's Range | 68.19 - 69.20 |
| 52 Week Range | 64.02 - 87.88 |
| Volume | |
| Avg. Volume | 1,848,017 |
| Market Cap | 16.431B |
| Beta (5Y Monthly) | 1.02 |
| PE Ratio (TTM) | 37.41 |
| EPS (TTM) | 1.83 |
| Earnings Date | Jan 30, 2024 - Feb 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 81.80 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-27% Est. Return
Subscribe to Yahoo Finance Plus to view Fair Value for HOLX
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- Hologic, Inc.Analyst Report: Hologic, Inc.Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.RatingFair ValueEconomic Moat28 days agoMorningstar
MedTech DiveDexcom, Hologic picked to outperform in 2024: William Blair
For the medtech industry overall, the analysts wrote that procedure volume growth is likely to normalize after declining due to the COVID-19 pandemic.
ZacksInvestors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Insider Monkey12 Stocks Billionaire Steve Cohen Just Bought and Sold
In this article, we’re going to take a look at 12 stocks billionaire Steve Cohen just bought and sold. To jump ahead to see the top picks that made our list, follow this link to read about the 5 Stocks Billionaire Steve Cohen just Bought and Sold. Billionaire Steve Cohen is one of the most […]
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.